Caption Management, LLC Milestone Pharmaceuticals Inc. Call Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$5.86 - $9.43 $886,618 - $1.43 Million	151,300 New	151,300 $1.39 Million
Q4 2021 Feb 11, 2022	SELL	$5.47 - $7.13 $902,550 - $1.18 Million	-165,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.28 - $6.29 $422,400 - $503,200	80,000 Added 94.12%	165,000 $942,000
Q1 2021 May 17, 2021	BUY	$5.79 - $8.85 $492,150 - $752,250	85,000 New	85,000 $493,000

25.1M

61.2K

38.8K

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $57M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.